4//SEC Filing
Degnan Chris 4
Accession 0000899243-21-003614
CIK 0001563577other
Filed
Jan 27, 7:00 PM ET
Accepted
Jan 28, 4:05 PM ET
Size
5.3 KB
Accession
0000899243-21-003614
Insider Transaction Report
Form 4
Degnan Chris
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-01-26+82,500→ 82,500 totalExercise: $11.99Exp: 2031-01-25→ Common Stock (82,500 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable in equal monthly installments over a four year period commencing January 26, 2021.
Documents
Issuer
Galera Therapeutics, Inc.
CIK 0001563577
Entity typeother
Related Parties
1- filerCIK 0001741968
Filing Metadata
- Form type
- 4
- Filed
- Jan 27, 7:00 PM ET
- Accepted
- Jan 28, 4:05 PM ET
- Size
- 5.3 KB